Scarica l'app Stockscreener
12.48
1.81%
-0.23
Dopo l'orario di chiusura:
12.48
Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie
Allspring Global Investments Holdings LLC Grows Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Pharma News: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Rating of "Buy" from Brokerages - marketbeat.com
Amneal Pharmaceuticals Stock: Generic Drug Leader Faces Recall Challenges Amid Sector Growth Opportu - ad-hoc-news.de
Tudor Investment Corp ET AL Takes Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
JPMorgan Chase & Co. Has $7.72 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by SG Americas Securities LLC - MarketBeat
Amneal Pharmaceuticals (AMRX) price target increased by 13.79% to 16.83 - MSN
AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Amneal (NYSE: AMRX) Co-CEO receives major performance-based RSU award - Stock Titan
[Form 4/A] Amneal Pharmaceuticals, Inc. Amended Insider Trading Activity - Stock Titan
Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openPR.com
Major holder Dipan Patel cuts Amneal Pharmaceuticals (AMRX) stake to 5.4% - Stock Titan
Vanguard (AMRX) disaggregates holdings, reports 0 Amneal shares after realignment - Stock Titan
Amneal Pharmaceuticals (NASDAQ: AMRX) posts 2025 growth and seeks backing for board slate - Stock Titan
Amneal Pharmaceuticals, Inc. $AMRX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Amneal Pharmaceuticals stock gains momentum as Truist raises target to $17 amid analyst optimism - AD HOC NEWS
Oliver Luxxe Assets LLC Purchases New Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. (AMRX) added to S&P SmallCap 600 Index, boosting investor visibility - msn.com
Aug Selloffs: Whats the fair value of Amneal Pharmaceuticals Inc stock2026 Price Momentum & Technical Confirmation Trade Alerts - baoquankhu1.vn
How Amneal’s Margin-Focused 2026 Outlook and 2025 Results Could Impact Amneal Pharmaceuticals (AMRX) Investors - simplywall.st
AMRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock? - MSN
Hydroxychloroquine Market Is Booming So Rapidly | Sanofi and Amneal Pharmaceuticals, LLC - openPR.com
A Look At Amneal Pharmaceuticals (AMRX) Valuation After Strong 2025 Results And 2026 Growth Guidance - Sahm
Stock Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2026 Fundamental Recap & Long-Term Investment Growth Plans - baoquankhu1.vn
Aug Analyst Calls: What are the future prospects of Amneal Pharmaceuticals IncPortfolio Gains Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Retail Surge: Will Amneal Pharmaceuticals Inc benefit from green energy policies2026 Winners & Losers & Community Verified Swing Trade Signals - baoquankhu1.vn
Amneal Pharmaceuticals: Flattish 2026 Revenue Growth Aside, Stock Still Looks A Buy (AMRX) - Seeking Alpha
Algert Global LLC Cuts Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Recalls Three Lots Of UTI Drug Over Concerns of Microbial Contamination: Retail Sticks To Bearish Territory - MSN
Capula Management Ltd Buys New Shares in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
AMRX PE Ratio & Valuation, Is AMRX Overvalued - Intellectia AI
Is Amneal Pharmaceuticals (AMRX) Pricing Reflect Its DCF Gap And Recent Share Slide - Yahoo Finance
Fed Meeting: Does Amneal Pharmaceuticals Inc stock have upside surprise potential2026 Weekly Recap & Community Consensus Trade Alerts - baoquankhu1.vn
Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Down 5.5%Here's What Happened - MarketBeat
Amneal Pharmaceuticals Inc (AMRX) Shares Gap Down to $12.73 on M - GuruFocus
Q4 Earnings Roundup: Amneal (NASDAQ:AMRX) And The Rest Of The Generic Pharmaceuticals Segment - Yahoo Finance
What Amneal Pharmaceuticals (AMRX)'s Return to Profitability and 2026 Guidance Means For Shareholders - simplywall.st
Amneal Pharmaceuticals Conference: “Amneal 2.0” Targets 2026 Growth in Biosimilars, CREXONT and AvKARE Shift - MarketBeat
Amneal (AMRX) Stock Analysis 2026: Strong Gains vs. Future Growth ConcernsNews and Statistics - IndexBox
Shorts Report: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdForecast Cut & Weekly Stock Breakout Alerts - baoquankhu1.vn
3 Reasons to Avoid AMRX and 1 Stock to Buy Instead - Finviz
AMRX: Biosimilars and specialty launches fuel growth, with profitability and global expansion accelerating - TradingView
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Best Value Stocks to Buy for March 9th - The Globe and Mail
Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - MSN
Trade Report: Will Amneal Pharmaceuticals Inc benefit from current market trends2026 Big Picture & Verified Trade Idea Suggestions - baoquankhu1.vn
Citigroup Inc. Purchases 101,166 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by Quantbot Technologies LP - MarketBeat
Goldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal to Participate in Upcoming Investor Conference - National Today
Amneal (AMRX) Co-CEO gains shares via RSU and performance awards - Stock Titan
Amneal (NYSE: AMRX) Co-CEO settles RSUs, withholds stock to cover taxes - Stock Titan
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):